LXRX - Lexicon stock rallies 18% amid FDA update $250M private placement
2024-03-11 12:15:43 ET
More on Lexicon Pharmaceuticals
- Lexicon Pharmaceuticals Putting The Pieces Together, But Much Is Left To Do
- Lexicon Pharma: Inpefa's Early Clinical Benefits, Rehospitalization Data May Unlock Significant Value
- Lexicon Pharmaceuticals: Navigating The Competitive HFpEF Landscape (Rating Downgrade)
- Lexicon announces oversubscribed $250M private placement of equity securities
- Lexicon Pharmaceuticals to offer up to $75M in common stock under agreement